Supplements
What Causes Low Mood in Endometriosis?
Women with endometriosis are up to three times more likely to experience depression than those without the condition — yet the mood component is rarely addressed at the same visit as the pelvic pain. Understanding the biological drivers behind low mood in endometriosis is the first step to actually doing something about it.
What Causes Low Mood in Endometriosis?
Low mood in endometriosis is real, measurable, and mechanistically distinct from ordinary stress. It is driven by chronic systemic inflammation, estrogen dominance disrupting serotonin synthesis, progesterone insufficiency, iron depletion from heavy bleeding, and often worsened by hormonal treatments that flatten the cycle entirely. Women with co-existing anxiety or depression benefit from addressing these root causes directly — but outcomes vary depending on which driver is dominant for each individual.
---
Why Endometriosis Is a Whole-Body Inflammatory Condition
Endometriosis is not simply a gynecological problem confined to the pelvis. Lesions produce and are sustained by a systemic inflammatory environment characterized by elevated prostaglandins, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and oxidative stress markers. This matters for mood because these same cytokines cross the blood-brain barrier and suppress the production of serotonin and dopamine by inhibiting the enzyme tryptophan hydroxylase-1 (TPH1).
A 2017 meta-analysis in Human Reproduction Update pooling data from more than 5,000 women found that endometriosis was associated with a significantly increased risk of depression (OR 1.80) and anxiety (OR 1.96), with the strongest associations in women with Stage III–IV disease — stages characterized by the highest inflammatory burden (Laganà et al., Human Reproduction Update 2017; PMID: 28938738).
This means that for many women with endometriosis, the low mood is not primarily psychological. It is a downstream signal of biology that can be partially modified by reducing inflammatory load.
Key inflammatory mechanisms linking endometriosis to low mood:
- Elevated IL-6 and TNF-α suppress tryptophan conversion to serotonin
- Prostaglandin E2 (PGE2) activates the hypothalamic-pituitary-adrenal (HPA) axis, raising cortisol
- Chronic pain itself triggers neuroinflammation and reduces dopaminergic reward signaling
- Oxidative stress depletes B vitamins and magnesium needed for neurotransmitter synthesis
---
What Causes Low Mood in a Heavy Period?
For women with endometriosis, menstruation is rarely a routine event. Retrograde bleeding, intense cramping, and prolonged flow create a monthly physiological crisis. The mood impact of heavy periods has a clear nutritional dimension: iron-deficiency anemia.
Heavy menstrual blood loss depletes ferritin, the body's stored form of iron. Iron is a required cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, and for monoamine oxidase — enzymes that regulate both mood and motivation. When ferritin falls below 30 ng/mL, dopaminergic and serotonergic tone both decline measurably, even in women who are not yet clinically anemic.
A 2012 study in Neuropsychiatric Disease and Treatment found a significant inverse relationship between serum ferritin levels and depressive symptom scores in premenopausal women, independent of hemoglobin levels (Vahdat Shariatpanaahi et al., Neuropsychiatric Disease and Treatment 2007; PMID: 19300581). This is clinically important: a woman can have normal hemoglobin and still have iron-mediated low mood if her ferritin is depleted.
The practical implication is that tracking ferritin — not just a CBC — is essential for any woman with endometriosis who experiences cyclical mood crashes. Mood swings and irritability often share these same nutritional root causes, and addressing iron status is frequently the fastest lever to pull.
---
What Causes Low Mood in Coming Off the Pill?
A large proportion of women with endometriosis are prescribed combined oral contraceptives (COCs) as first-line hormonal management. When they eventually stop — whether to conceive, because of side effects, or because the pill stops working — many report a period of significant low mood that can last weeks to months.
There are at least three distinct mechanisms at work:
- Sex hormone-binding globulin (SHBG) rebound lag. The pill dramatically raises SHBG, which binds testosterone. After stopping, SHBG remains elevated for months while total testosterone slowly recovers, leaving free testosterone suppressed — and testosterone plays a significant role in mood, motivation, and libido in women.
- B6 and folate depletion. COCs are well-documented to deplete pyridoxal-5-phosphate (active B6), which is the critical cofactor for the conversion of 5-hydroxytryptophan (5-HTP) into serotonin. A 2021 cross-sectional study in BJOG found that women taking oral contraceptives had significantly lower plasma vitamin B6 concentrations and higher rates of depressive symptoms compared to non-users (Skovlund et al., JAMA Psychiatry 2016; PMID: 27680324).
- Progesterone withdrawal without recovery. The progestins in COCs partially replace endogenous progesterone. On cessation, natural progesterone production takes time to re-establish, and this gap — during which allopregnanolone (a neurosteroid with GABAergic anxiolytic effects) is low — creates a window of increased anxiety and mood instability.
Recovering from hormonal contraceptive use is one of the more underserved areas of women's health, and it sits squarely in the intersection of endocrine function and nutritional repletion. Understanding the hormonal and nutritional drivers of low libido is often part of the same post-pill recovery picture.
---
What Causes Low Mood in Menopause With Endometriosis?
Endometriosis does not always resolve at menopause. Lesions can remain active in the presence of adipose-derived estrogen or exogenous hormone therapy, and the menopause transition itself layers a new set of mood-disrupting mechanisms on top of the existing inflammatory substrate.
Estrogen decline at perimenopause reduces serotonin receptor sensitivity and decreases the activity of monoamine oxidase — the same pathway disrupted by endometriosis-driven inflammation. The net effect is a compounded risk. A large prospective cohort study in JAMA Psychiatry found that the risk of a first depressive episode increased 1.8-fold during perimenopause compared to premenopause, even after adjusting for prior mood history (Cohen et al., JAMA Psychiatry 2006; PMID: 16894061).
For women with endometriosis entering perimenopause or surgical menopause (post-oophorectomy), this dual burden — persistent inflammatory signaling from residual lesions plus the neurochemical consequences of estrogen withdrawal — creates a particularly challenging mood environment. Vitamin D insufficiency, which is also prevalent in endometriosis (likely due to chronic inflammation consuming 25-OH-D), compounds this further. Low vitamin D is linked to impaired serotonin synthesis and increased depression risk, and should always be checked in this population.
---
What Causes Low Mood in Men With Low Testosterone? (And Why It's Relevant Here)
This may seem like a detour, but the testosterone-mood pathway is directly relevant to women with endometriosis. Testosterone is not exclusively a male hormone. Women produce testosterone in the ovaries and adrenal glands, and it contributes meaningfully to energy, motivation, and emotional resilience. The same biological mechanism that produces low mood in men with low testosterone — reduced androgen receptor signaling in the prefrontal cortex and limbic system — operates in women when free testosterone is suppressed.
In the context of endometriosis, testosterone can be suppressed through several routes:
- COC use elevating SHBG (as described above)
- Adrenal fatigue from chronic HPA axis activation
- Low cholesterol (the substrate for all steroid hormones) resulting from restrictive eating in response to chronic pain
- Zinc and magnesium depletion, both of which are needed for testosterone synthesis
Addressing androgen status in women is rarely part of standard endometriosis care, but from a functional medicine perspective, it is a meaningful contributor to mood and quality of life.
---
The Nutrient Depletion Map in Endometriosis
Chronic inflammation, heavy bleeding, and hormonal treatment create predictable nutrient deficits in endometriosis. Understanding this map is essential for targeted intervention:
| Nutrient | Why It's Depleted | Mood-Relevant Role |
|---|---|---|
| Magnesium | Consumed by inflammatory pathways; lost in heavy bleeding | NMDA receptor modulation; cortisol regulation |
| Vitamin D | Suppressed by chronic inflammation; poor conversion | Serotonin synthesis cofactor; neuroimmune regulation |
| Zinc | Depleted by COCs and chronic oxidative stress | BDNF production; hippocampal neurogenesis |
| Iron (ferritin) | Lost via heavy menstrual bleeding | Dopamine and serotonin enzyme cofactor |
| B6 (P5P) | Depleted by COCs; consumed in transamination reactions | Serotonin, dopamine, GABA synthesis |
| Omega-3 (EPA) | Low in inflammatory diets; out-competed by omega-6 | Anti-inflammatory; phospholipid membrane integrity |
A 2019 randomized controlled trial in Archives of Gynecology and Obstetrics found that omega-3 supplementation significantly reduced both dysmenorrhea severity and depression scores in women with endometriosis over 12 weeks, compared to placebo (Sadeghi et al., Archives of Gynecology and Obstetrics 2019; PMID: 31147845).
---
What This Means for Your Formula
Ones uses AI analysis of blood work, wearable data, and health history to identify which of these drivers is actually active for a given individual — rather than recommending a blanket protocol. For someone flagged with endometriosis-pattern inflammation and low mood, the formula is typically built around a few high-priority actives:
Omega-3 (EPA/DHA): Ones includes pharmaceutical-grade EPA and DHA dosed to clinical ranges. The anti-inflammatory effect of EPA — specifically its competition with arachidonic acid for COX-2 — directly addresses the PGE2-driven inflammation that suppresses serotonin synthesis. The mood-relevant dose in trials is typically ≥1g EPA/day, and Ones calibrates to this range based on dietary intake data.
Vitamin D3 + K2 (MK-7): Women with endometriosis consistently test low in 25-OH-D. Ones includes D3 paired with MK-7 to support calcium trafficking and avoid soft-tissue calcification at higher D3 doses. The D3 dose is individualized based on blood levels, not a flat 1,000 IU — which is rarely sufficient to correct deficiency. Correcting vitamin D status is also one of the most impactful interventions for seasonal and hormonal low mood.
Magnesium Complex: Ones' Magnesium Complex includes glycinate and malate forms — the glycinate fraction crosses the blood-brain barrier efficiently and has been studied for anxiolytic and sleep-supportive effects. Magnesium is also required for vitamin D activation (the conversion of calcidiol to calcitriol requires magnesium-dependent enzymes), making it foundational when D3 is also in the formula.
For women in the post-pill recovery phase or with suspected zinc depletion, individual zinc supplementation may also be included, dosed to clinical ranges that support BDNF expression without risking copper displacement.
---
Key Takeaways
- Low mood in endometriosis is biologically driven — primarily by systemic inflammation, not psychological fragility. Cytokines like IL-6 and TNF-α directly suppress serotonin and dopamine synthesis.
- Heavy periods create iron depletion that impairs dopaminergic tone even before clinical anemia appears. Ferritin below 30 ng/mL is clinically significant for mood.
- Coming off the pill triggers a multi-week mood dip from SHBG rebound suppressing free testosterone, B6 depletion, and progesterone withdrawal — all addressable with targeted nutrients.
- Perimenopause compounds the inflammatory mood burden — estrogen decline reduces serotonin receptor sensitivity, and vitamin D insufficiency is almost universal in this group.
- Nutrient depletion is predictable and measurable — magnesium, vitamin D, zinc, omega-3, iron, and B6 are the primary targets and should all be tested, not guessed.
- A personalized formula outperforms a generic one — because which driver is dominant varies by individual lab results, cycle stage, and treatment history. Ones builds formulas calibrated to actual biomarker data, not population averages.